Phosphodiesterase 4-targeted treatments for autoimmune diseases

@inproceedings{Kumar2013Phosphodiesterase4T,
  title={Phosphodiesterase 4-targeted treatments for autoimmune diseases},
  author={Neal Kumar and Ari M Goldminz and Noori Kim and Alice Bendix Gottlieb},
  booktitle={BMC medicine},
  year={2013}
}
Advancements in phosphodiesterase (PDE)-targeted therapies have shown promise in recent years for treating patients with a variety of autoimmune diseases. This review summarizes the development of PDE4 inhibitors and the associated literature with a focus on treatments for autoimmune diseases. After the initial investigations of the prototypic PDE inhibitor, rolipram, more selective inhibitors targeting the PDE4 isozyme have been developed. With phase II and phase III clinical trials currently… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 78 references

Similar Papers

Loading similar papers…